Cilnidipine
Article about the calcium channel blocker Cilnidipine
Cilnidipine | |
---|---|
![]() | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
Cilnidipine is a calcium channel blocker used in the management of hypertension. It is a dual blocker of L-type and N-type calcium channels, which makes it unique among calcium channel blockers.
Pharmacology[edit | edit source]
Cilnidipine is a dihydropyridine calcium channel blocker. It works by inhibiting the influx of calcium ions into vascular smooth muscle and cardiac muscle, leading to vasodilation and a reduction in blood pressure. The dual action on L-type and N-type calcium channels provides additional benefits in terms of reducing sympathetic nerve activity.
Mechanism of Action[edit | edit source]
Cilnidipine blocks L-type calcium channels, which are primarily found in the vascular smooth muscle and the heart. This action leads to vasodilation and decreased peripheral resistance. Additionally, cilnidipine blocks N-type calcium channels, which are located in the sympathetic nervous system. This reduces the release of neurotransmitters such as norepinephrine, further contributing to its antihypertensive effects.
Clinical Use[edit | edit source]
Cilnidipine is primarily used for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents. The dual action on both L-type and N-type calcium channels makes it particularly effective in patients with high sympathetic nerve activity.
Side Effects[edit | edit source]
Common side effects of cilnidipine include dizziness, flushing, headache, and peripheral edema. These are typical of calcium channel blockers due to their vasodilatory effects. Rarely, it may cause bradycardia or hypotension.
Dosage and Administration[edit | edit source]
Cilnidipine is administered orally, usually once daily. The dosage may vary based on the patient's response and the severity of hypertension. It is important to follow the prescribing physician's instructions and not to discontinue the medication abruptly.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD